Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer
KEYNOTE-407
Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
2517
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
pembrolizumab
100%
Non-Small Cell Lung Carcinoma
63%
Drug Therapy
41%
Confidence Intervals
31%
Placebos
30%
Albumin-Bound Paclitaxel
28%
Survival
24%
Progression-Free Survival
24%
Carboplatin
19%
Paclitaxel
17%
Nanoparticles
15%
Ligands
12%
Platinum
9%
Disease Progression
7%
Therapeutics
2%
Neoplasms
2%